Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
David Sidransky Insider Profile
4 Followers
David Sidransky, Director at Akari Therapeutics, holds 0.00 shares in Ayala Pharmaceuticals (Ticker: AYLA), holds 139.00 shares in Advaxis (Ticker: ADXS), holds 767.04K shares in Champions Oncology (Ticker: CSBR).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-32.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David Sidransky holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Sidransky
David Sidransky's Trading History
Akari Therapeutics
Jan 02, 2015
Director
Uninformative Buy
―
$66.23K
Champions Oncology
Oct 14, 2022
Director
Uninformative Buy
15.31K
$7.03M
Orgenesis
Jan 11, 2021
Director
Informative Buy
1.07K
$291.60
Ayala Pharmaceuticals
Jan 23, 2023
―
Uninformative Sell
―
$0.00
Advaxis
Jan 23, 2023
Director
Uninformative Buy
―
$3.75
Immune Pharmaceuticals
Jan 12, 2015
―
Uninformative Buy
―
$216.99
List of latest transactions for each holding click on a transaction to see David Sidransky's performance on stock
You May Also Like
David Sidransky insider profile FAQ
What is the percentage of profitable transactions made by David Sidransky?
The percentage of profitable transactions made by David Sidransky is 25%.
What is the average return per transaction made by David Sidransky?
The average return per transaction made by David Sidransky is -32.30%.
What stocks does David Sidransky hold?
David Sidransky holds: AKTX, CSBR, ORGS, AYLA, ADXS, IMNPQ stocks.
What was David Sidransky’s latest transaction?
David Sidransky latest transaction was an Uninformative Sell of ―.
What was David Sidransky's most profitable transaction?
David Sidransky’s most profitable transaction was an Informative Sell of ADXS stock on August 10, 2016. The return on the trade was 58.90%.
What is David Sidransky's role in Akari Therapeutics?
David Sidransky's role in Akari Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.